Ausgabe 2/2006
Inhalt (8 Artikel)
Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesis
Caroline J. Taylor, Kouros Motamed, Brenda Lilly
Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay
Sheng Tong, Qing Chen, Si-Qing Shan, Mark W. Dewhirst, Fan Yuan
In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease
Caroline Schultheiss, Birgit Blechert, Florian C. Gaertner, Enken Drecoll, Jan Mueller, Georg F. Weber, Alexander Drzezga, Markus Essler
Angiogenesis treatment, new concepts on the horizon
Robert J. Griffin, Grietje Molema, Ruud P.M. Dings
Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients
Christian Parr, Chun H. Gan, Gareth Watkins, Wen G. Jiang
Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis
Masahiro Asakage, Nelson H. Tsuno, Joji Kitayama, Takeshi Tsuchiya, Satomi Yoneyama, Jun Yamada, Yurai Okaji, Shoichi Kaisaki, Takuya Osada, Koki Takahashi, Hirokazu Nagawa
Tissue Endostatin Correlates Inversely with Capillary Network in Rat Heart and Skeletal Muscles
Jian-Wei Gu, Megan Shparago, Wei Tan, Amelia Purser Bailey
Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells
Jose G. Trevino, Michael J. Gray, Steffan T. Nawrocki, Justin M. Summy, Donald P. Lesslie, Douglas B. Evans, Tomi K. Sawyer, William C. Shakespeare, Stephanie S. Watowich, Paul J. Chiao, David J. McConkey, Gary E. Gallick